all news

Tue, 22 Apr 2025 HTC- HRTECHCUBE

AI Boosts Qstream’s Growth and Customer Value Potential

Tue, 22 Apr 2025 Business Wire

OM1 Adds 1 Million Patients to Its Mental Health Network, Significantly Expanding Specialty Coverage and Driving New Possibilities for Real-World Research and Personalized Care

Wed, 16 Apr 2025 Associated Press

Propy Partners with Proof to Streamline Notary Services, Making Home Buying Faster and Safer

Thu, 10 Apr 2025 Business Wire

Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S-4321, a Novel Bifunctional Antibody that Agonizes PD-1 and FcγRIIb Inhibitory Receptors for the Treatment of Autoimmune Disease

Tue, 8 Apr 2025 PR Newswire

Engine Biosciences and Experimental Drug Development Centre Partner to Advance Novel Therapies to Combat Cancer

Thu, 3 Apr 2025 GlobeNewswire

Auron Presents New Preclinical Data for AUTX-703 in Small Cell Lung Cancer (SCLC)

Thu, 20 Mar 2025 Business Wire

Podimetrics and Alivi Health Announce New Partnership to Support Diabetic Foot Health

Thu, 20 Mar 2025 GlobeNewswire

PathAI Announces EMA Qualification for AIM-MASH AI Assist, a Groundbreaking AI Tool for MASH Clinical Trials

Wed, 19 Mar 2025 GlobeNewswire

FloQast Named “Best Finance Automation Platform” in 2025 FinTech Breakthrough Awards

Sun, 16 Mar 2025 Associated Press

Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Fri, 14 Mar 2025 GlobeNewswire

Mass Technology Leadership Council Announces Tech Top 50

Wed, 12 Mar 2025 Associated Press

OM1 Expands into Europe to Strengthen Support for Life Sciences with AI-Driven Real-World Evidence Solutions

Wed, 12 Mar 2025 Associated Press

QurAlis Announces Topline Data From its Phase 1 Clinical Trial of QRL-101 Evaluating Biomarkers of ALS and Epilepsy in Healthy Volunteers

Tue, 11 Mar 2025 Associated Press

Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S‑1117, a Novel Pan‑IgG Protease Therapy for Antibody-Mediated Diseases

Tue, 4 Mar 2025 PR Newswire

Ajax Health and KKR Form New Platform to Develop System for Treating Heart Failure

Fri, 28 Feb 2025 Business Wire

Seismic Therapeutic Presents Preclinical Data on S-8484, Its Novel IgE Protease, for Treatment of Allergic Diseases

Tue, 25 Feb 2025 egnyte.com

Egnyte Announces Majority Investment from GI Partners and TA

Mon, 24 Feb 2025 Associated Press

Auron Therapeutics Announces AUTX-703 Granted Fast Track Designation by the FDA for Relapsed or Refractory Acute Myelogenous Leukemia

Wed, 12 Feb 2025 50 States Today

PathAI and Rede D’Or Announce Strategic Partnership to Bring AI-Powered Pathology Solutions to Brazil

Tue, 4 Feb 2025 Associated Press

Auron Therapeutics Announces FDA Clearance to Initiate Clinical Development of AUTX-703 and Completion of Series B Financing

Mon, 3 Feb 2025 TipRanks

Tectonic Therapeutic Secures $185 Million in PIPE Deal

Thu, 30 Jan 2025 GlobeNewswire

Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF

Wed, 29 Jan 2025 Business Wire

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular At

Wed, 29 Jan 2025 Associated Press

Cohere Health Unveils Cohere Connect™ to Address Prior Authorization Compliance Gaps for Health Plans

Wed, 29 Jan 2025 GlobeNewswire

Dewpoint Therapeutics Announces DPTX3496 as a Development Candidate for the Treatment of Colorectal, Breast, and Lung Cancers

Tue, 28 Jan 2025 Business Wire

Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO

Wed, 22 Jan 2025 Associated Press

FloQast Cements Industry Leadership in Ethical, Responsible, and Auditable AI Development with ISO 42001 Certification

Wed, 22 Jan 2025 Global Venturing

Singapore becomes refuge for investors and startups escaping US-China tensions

Wed, 22 Jan 2025 Associated Press

CoV Biotechnology Takes Next Step to Become Leyden Labs Asia

Wed, 15 Jan 2025 Associated Press

Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies